0001437749-15-010869.txt : 20150521 0001437749-15-010869.hdr.sgml : 20150521 20150521190951 ACCESSION NUMBER: 0001437749-15-010869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150519 FILED AS OF DATE: 20150521 DATE AS OF CHANGE: 20150521 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000806888 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1781 - 75TH AVENUE W. CITY: VANCOUVER STATE: A1 ZIP: V6P6P2 BUSINESS PHONE: 604-456-6010 MAIL ADDRESS: STREET 1: 1781 - 75TH AVENUE W. CITY: VANCOUVER STATE: A1 ZIP: V6P6P2 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shuster Lewis CENTRAL INDEX KEY: 0001471131 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50571 FILM NUMBER: 15884168 MAIL ADDRESS: STREET 1: 421 BRIDOON TERRACE CITY: ENCINITAS STATE: CA ZIP: 92024 4 1 rdgdoc.xml FORM 4 X0306 4 2015-05-19 0000806888 RESPONSE BIOMEDICAL CORP RBM 0001471131 Shuster Lewis 1781 - 75TH AVENUE W. VANCOUVER A1 V6P 6P2 BRITISH COLUMBIA, CANADA 1 Common Stock 2015-05-19 4 A 0 10763 0 A 68615 D 100% of the restricted share units vested on the date of grant. The expiration date for each of the restricted share units will be the earlier of three (3) years after the effective date or two (2) years following the grantee's termination date. The reporting person has elected to defer receipt of the common stock underlying the restricted share units until a later date not to exceed the expiration date. /s/ Anastasios Tsonis, Attorney in Fact 2015-05-21